therapies. He is member of several national (AIOM, AIOT, CTPG) and international scientific societies (ASCO, ESMO,
IASLC). He is President of the Italian Association of Thoracic Oncology (AIOT). He is a past member of the Foundation
Council of the European Thoracic Oncology Platform (ETOP). He is member of Advisory Board of scientific journals and
of several expert panels. Dr. Gridelli has been invited as speaker at international conferences and educational activities
of oncology societies (ASCO, ESMO etc.). He gave 2 oral presentation and 5 talks as faculty member at the annual ASCO
meetings. He is author or co-author of more than 750 papers, of which more than 370 extended papers published on
international indexed journals, and several chapters of books. His papers have about 16,378 citations on international
indexed journals. Dr. Gridelli has an h-index of 62. On November 2013 the American agency Expertscape (Palo Alto,
California) appointed Dr. Gridelli at the first place among the top world experts on lung cancer.
Speaker Abstract(s): S15
Diakonessenhuis, Geriatric Medicine, Utrecht, Netherlands
Marije Hamaker has been working as a clinical geriatrician working at the Diakonessenhuis in Utrecht, the Netherlands
since 2010. In 2012, she defended her PhD thesis on “Decision making in geriatric oncology”. She has remained active in
geriatric oncology research, focussing on treatment decisions and patient-centred outcome measures in various cancer
types, and additionally has set up a project regarding geriatric nephrology in 2014. She is an active member of the Dutch
Geriatric Oncology Foundation, the Elderly Task Force of the EORTC as well as a member of SIOG and the Dutch
Speaker Abstract(s): S16
University of Texas Health Science Center, Division of Geriatric and Palliative Medicine, Houston, USA
Dr. Holly Holmes is a geriatrician and is the division director for Geriatric & Palliative Medicine at the University of
Texas Health Science Center at Houston McGovern Medical School. Her clinical care and research interests center on
geriatric assessment and providing optimal medical and pharmacologic care for older, vulnerable adults.
Speaker Abstract(s): S18
Medical Oncology, Duarte, USA
Dr. Arti Hurria is a geriatrician and oncologist and is Director of the Cancer and Aging Research Program at City of
Hope. The overall goal of Dr. Hurria’s research program is to improve the care of older adults with cancer. Under Dr.
Hurria’s leadership, the Cancer and Aging Research Program has developed and executed over 22 geriatric oncology
protocols, enrolling over 3100 participants on studies focused on cancer and aging. Dr. Hurria is principal investigator
on 6 NIH-funded grants and has received research support from the Breast Cancer Research Foundation, UniHealth
Foundation, and Hearst Foundation. Dr. Hurria leads national and international efforts to improve the care of older
adults with cancer. She served as the President for the International Society of Geriatric Oncology from 2012 to 2014.
She was a member of the Committee on “Improving the Quality of Cancer Care: Addressing the Challenges in an Aging
Population” for the Institute of Medicine. Since 2010, Dr. Hurria has served as the Editor-in-Chief for the Journal of
Geriatric Oncology. She was the recipient of the B.J. Kennedy Award from the American Society of Clinical Oncology,
which recognizes scientific excellence in geriatric oncology. In 2016, Dr. Hurria was elected to the Board of Directors for
the American Society of Clinical Oncology.
Speaker Abstract(s): S19
National Cancer Centre Singapore, Medical Oncology, Singapore, Singapore
Dr Ravindran Kanesvaran is a Consultant in the Department of Medical Oncology of the National
Singapore. He is also an Assistant Professor at Duke-NUS Graduate Medical School and clinical senior lecturer at the
Yong Loo Lin School of Medicine, National University of Singapore. He is actively involved in graduate medical education
and is a core faculty member of the Medical Oncology Senior Residency Program and the Singhealth Internal Medicine
completed his medical oncology speciality training in the National Cancer Centre Singapore.
After completion of that training he followed up with a fellowship in genitourinary oncology (GU) and geriatric oncology
in Duke Cancer Institute in North Carolina, USA on a Healthcare Manpower Development Program (HMDP) scholarship
awarded by the Ministry of Health Singapore. His research interests include GU oncology and geriatric oncology. He
has published in a number of well-known peer reviewed journals including Journal of Clinical Oncology and Lancet
He has also been awarded a number of awards including the American Society of Clinical Oncology (ASCO GU) Merit
Award 2009, American Association for Cancer Research (AACR) scholar-in-training Award 2010 and European Society
of Medical Oncology (ESMO) fellowship award 2012. He is currently the President of the Singapore Society of Oncology